Find trending articles through Social News Discovery®! Providing a collaboration of news through social media technologies.
Follow your friends and create your own Online Social Newspaper! Invite your friends to follow you from Facebook. Filter the news articles you see by section, clipper, or mood. Rate each article and comment on all news clips!
Receive site and email notifications about comments and news clips that you are collaborating on!
Get the latest news on the Everyone page, the viral and trending news clips will always be at the top! See the trending news and articles!
"The FDA today granted accelerated approval to nivolumab for treatment of certain patients with classical Hodgkin lymphoma.Nivolumab (Opdivo, Bristol-Myers Squibb) is indicated for patients who relapsed or progressed after autologous hematopoietic stem cell transplant (HSCT) and posttransplant brentuximab vedotin (Adcetris, Seattle Genetics).", www.healio.com
"The FDA approved nivolumab (Opdivo) for the treatment of patients with classical Hodgkin lymphoma that has relapsed or progressed after autologous hematopoietic stem cell transplantation and posttransplantation brentuximab vedotin (Adcetris).", global.onclive.com
"The FDA has granted an accelerated approval to nivolumab for patients with classical Hodgkin lymphoma following relapse or progression after autologous hematopoietic stem cell transplantation and post-transplantation brentuximab vedotin.", www.targetedonc.com